Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Coliseum Capital’s 13D On LHC Group, Inc. (LHCG) & Cross-Trade Transactions

Following 13D filings from the SEC is important, and not only when it comes to changes in notable investors’ equity portfolios per se, but also when hedge funds disclose other moves that caused them issue the filing. Coliseum Capital, an activist hedge fund managed by Christopher Shackelton and Adam Gray, recently filed an amendment to its 13D filing which discloses their ownership of 2.6 million shares of LHC Group, Inc. (NASDAQ:LHCG), with the value of the stake amounting to $57.4 million (at current prices)


Even though the amendment did not involve any changes in the number of shares held, it disclosed some information that might be useful for retail investors. The filing disclosed the list of entities that hold the LHC Group, Inc. (NASDAQ:LHCG) stock, and you can see them below:

Explanatory Note: This Amendment No. 2 (this “Amendment”), to the Schedule 13D (the “Initial 13D”) filed by the Filers (as defined below in Item 2) with the U.S. Securities and Exchange Commission (the “Commission”) on November 16, 2012, as amended and supplemented by Amendment No. 1 to the Initial 13D filed on March 14, 2013, amends and supplements the items set forth herein. As used in this statement, the term “Filers” collectively refers to:

• Coliseum Capital Management, LLC, a Delaware limited liability company (“CCM”);

• Coliseum Capital, LLC, a Delaware limited liability company (“CC”);

• Coliseum Capital Partners, L.P., a Delaware limited partnership (“CCP”);

• Coliseum Capital Partners II, L.P., a Delaware limited partnership (“CCP2”);

• Blackwell Partners, LLC, a Georgia limited liability company (“Blackwell”);

• Adam Gray (“Gray”); and

• Christopher Shackelton (“Shackelton”).

Also, the filing mentioned cross-trade transactions, not included in the open market: “On September 16, 2013, CCP2 acquired 127,678 shares of Stock from CCP and 59,609 shares of Stock from Blackwell.”

Aside from Coliseum, we should mention some other hedge funds that have been bullish on LHC Group, Inc. (NASDAQ:LHCG) in the latest round of 13F filings, including Aqr Capital Management, managed by Cliff Asness, Steven Cohen’s Sac Capital Advisors, and Joel Greenblatt’s Gotham Asset Management.

Recommended Reading:

Activist Jana Partners Buys a Boatload of Safeway Inc. (SWY)

Billionaire Carl Icahn Unloads Some WebMD Health Corp. (WBMD) Shares

Mario Gabelli On Tesla Motors Inc (TSLA) & Elon Musk: ‘I Am Not So Sure He Should Be Selling Direct’

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!